BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 113518
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.113518
Table 5 Survival outcomes according to recurrence status, %
Group
n
OS, median (95%CI), months
1-year OS
3-year OS
5-year OS
P value
Overall cohort38631.2 (27.8-34.6)82.442.728.3
By recurrence status
No recurrence14958.7 (52.3-65.1)96.671.854.2Reference
Early recurrence17818.5 (16.2-20.8)71.318.05.1< 0.001
Late recurrence5942.3 (36.7-47.9)10052.523.7< 0.001
Post-recurrence survival
Early recurrence1789.8 (8.4-11.2)38.28.42.8Reference
Late recurrence5918.6 (14.9-22.3)71.225.410.2< 0.001
By treatment of recurrence
Repeat resection/RFA3428.3 (21.7-34.9)82.435.317.6Reference
Locoregional therapy6719.2 (15.8-22.6)71.619.47.50.012
Systemic chemotherapy11212.4 (10.1-14.7)51.88.90< 0.001
Best supportive care243.1 (2.2-4.0)4.200< 0.001


Write to the Help Desk